Summary: Can a placebo alone produce a psychedelic experience? New research from McGill University suggests it can, under the right conditions.
Source: McGill University
Recent interest in psychedelic-assisted therapy for depression and other mental health conditions has highlighted the powerful role of subjective experience. A study from McGill shows that, when expectations and environment are carefully shaped, many people can report psychedelic-like changes in consciousness after taking an inert substance. The researchers documented some of the strongest placebo responses related to consciousness reported in the psychedelic literature: 61% of participants verbally reported experiencing effects after consuming a placebo.
“The study highlights how strongly context can shape psychedelic experiences,” said Jay Olson, a Ph.D. candidate in McGill’s Department of Psychiatry and lead author of the published paper in Psychopharmacology. “As psychedelic therapies re-emerge for conditions such as depression and anxiety, clinicians might be able to use contextual elements to elicit therapeutic experiences with lower drug doses, potentially improving safety.”
Setting the mood
To test whether context alone could produce psychedelic-like effects, the research team designed a naturalistic, four-hour group session that resembled a typical psychedelic party. Thirty-three student participants were invited to a room decorated with paintings, colored lights and visual projections, with music provided by a DJ. The team also staged credible scientific apparatus and personnel to bolster expectations: ten research assistants in white lab coats, psychiatrists, and even a security guard were present to create a convincing experimental atmosphere.
Participants were told they would receive a substance resembling the active ingredient in psychedelic mushrooms (psilocybin) and that they would likely experience changes in perception and consciousness during the session. In reality, every participant consumed a placebo. To further strengthen the credibility of the setup, trained confederates (actors embedded among participants) subtly enacted the expected effects over time, helping to foster the impression that everyone had taken a genuine psychedelic.
Strong effects for a placebo
At the end of the session, participants completed measures of altered consciousness and were asked about their experiences. Results showed wide individual variation: while some people reported no noticeable change, many described effects typically associated with moderate or even high doses of psilocybin. Overall, 61% verbally reported some effect from the placebo. Descriptions included perceptual shifts such as paintings appearing to move or reshape, bodily sensations of increased heaviness or altered gravity, and waves of intensity with rises and declines in subjective experience. One participant described a “come down” followed by another “wave,” and several participants expressed certainty that they had received an active psychedelic substance.
Samuel Veissière, a cognitive anthropologist in McGill’s Department of Psychiatry who supervised the study, noted that these findings may help explain social phenomena such as “contact highs,” where people feel drug effects simply by being around others who have taken a substance. He emphasized that the study also highlights the role of social and contextual influences in amplifying placebo effects across medical and therapeutic settings. For example, the growing practice of “micro-dosing” psychedelics—taking very small amounts to boost creativity—may rely heavily on cultural expectations and placebo-related mechanisms, Veissière suggested.
Source:
McGill University
Media Contacts:
Katherine Gombay – McGill University
Image Source:
The image is credited to McGill University.
Original Research: Closed access
“Tripping on nothing: placebo psychedelics and contextual factors”. Jay A. Olson, Léah Suissa-Rocheleau, Michael Lifshitz, Amir Raz & Samuel P. L. Veissière. Psychopharmacology doi: 10.1007/s00213-020-05464-5.
Abstract
Tripping on nothing: placebo psychedelics and contextual factors
Rationale
Can a placebo by itself produce a psychedelic experience? While most controlled psychedelic trials report minimal effects among placebo groups, those outcomes may be influenced by study design, environmental context, or how results are analyzed.
Objective
The researchers investigated individual differences in placebo responses within a naturalistic environment intentionally modeled after a typical psychedelic social setting.
Methods
Thirty-three student volunteers took part in a single-arm study that was presented as research on how a psychedelic affects creativity. Over four hours, participants gathered in a group setting with ambient music, paintings, colored lighting and visual projections. Each person consumed an inert placebo described as a substance similar to psilocybin. To heighten expectations, confederates discreetly acted out the drug’s effects, and participants were led to believe there was no placebo control condition. After the session, participants completed the 5-Dimensional Altered States of Consciousness Rating Scale to assess changes in conscious experience.
Results
Placebo responses varied widely: many participants reported no effects, while others reported experiences with intensities typically associated with moderate or high doses of psilocybin. Sixty-one percent of participants verbally reported some effect. Reports included visual changes—paintings that seemed to move or alter their shape—bodily sensations of increased weight or altered gravity, and alternating waves of intensity in subjective experience.
Conclusion
Investigating how context and expectation can elicit psychedelic-like experiences without pharmacological intervention helps researchers distinguish true drug effects from context-driven responses and can inform clinical practice. Understanding these mechanisms may enable clinicians to maximize therapeutic benefit while minimizing drug exposure.